132 related articles for article (PubMed ID: 31140872)
21. [The Choice of Anticoagulant Therapy in Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease].
Koziolova NA; Polyanskaya EA; Kolegova II
Kardiologiia; 2017 Jan; (1):76-85. PubMed ID: 28290837
[TBL] [Abstract][Full Text] [Related]
22. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
[TBL] [Abstract][Full Text] [Related]
23. Real-World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study.
Biteker M; Başaran Ö; Doğan V; Altun İ; Özpamuk Karadeniz F; Tekkesin Aİ; Çakıllı Y; Türkkan C; Hamidi M; Demir V; Gürsoy MO; Tek Öztürk M; Aksan G; Seyis S; Ballı M; Alıcı MH; Bozyel S
J Am Geriatr Soc; 2017 Aug; 65(8):1684-1690. PubMed ID: 28394435
[TBL] [Abstract][Full Text] [Related]
24. Use of oral anticoagulants in complex clinical situations with atrial fibrillation.
Gullón A; Sánchez Fuentes D; López-de-Sá E; Martí-Almor J; Barón-Esquivias G; Jiménez López J; Del Mar Contreras Muruaga M; Suárez Fernández C
Med Clin (Barc); 2018 Jun; 150 Suppl 1():8-24. PubMed ID: 30502871
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras.
Brown JD; Shewale AR; Dherange P; Talbert JC
Drugs Aging; 2016 Jun; 33(6):427-36. PubMed ID: 27154397
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence of Advanced Chronic Kidney Disease in Patients with Nonvalvular Atrial Fibrillation Hospitalized in Cardiology Departments].
Chashkina MI; Kozlovskaya NL; Andreev DA; Ananicheva NA; Bykova AA; Salpagarova ZK; Syrkin AL
Kardiologiia; 2020 Mar; 60(2):41-46. PubMed ID: 32345197
[TBL] [Abstract][Full Text] [Related]
27. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GYH
Chest; 2014 Jun; 145(6):1370-1382. PubMed ID: 24356875
[TBL] [Abstract][Full Text] [Related]
29. Oral anticoagulants usage in Japanese patients aged 18-74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data.
Ohshima A; Koyama T; Ogawa A; Zamami Y; Tanaka HY; Kitamura Y; Sendo T; Hinotsu S; Miller MW; Kano MR
Fam Pract; 2019 Nov; 36(6):685-692. PubMed ID: 31329899
[TBL] [Abstract][Full Text] [Related]
30. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
[TBL] [Abstract][Full Text] [Related]
31. Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation.
Manzano-Fernández S; Andreu-Cayuelas JM; Marín F; Orenes-Piñero E; Gallego P; Valdés M; Vicente V; Lip GY; Roldán V
Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):497-504. PubMed ID: 25457087
[TBL] [Abstract][Full Text] [Related]
32. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.
Potpara TS; Dagres N; Mujović N; Vasić D; Ašanin M; Nedeljkovic M; Marin F; Fauchier L; Blomstrom-Lundqvist C; Lip GY
Adv Ther; 2017 Feb; 34(2):357-377. PubMed ID: 27933569
[TBL] [Abstract][Full Text] [Related]
33. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
[TBL] [Abstract][Full Text] [Related]
34. Commonly used definitions in real-world studies may underestimate the prevalence of renal disease among nonvalvular atrial fibrillation patients.
Schultze A; Graham S; Nordstrom BL; Mehmud F; Ramagopalan SV
J Comp Eff Res; 2019 Sep; 8(12):961-968. PubMed ID: 31317772
[No Abstract] [Full Text] [Related]
35. Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease.
Potpara TS; Jokic V; Dagres N; Larsen TB; Lane DA; Hindricks G; Lip GY
Curr Med Chem; 2016; 23(19):2055-69. PubMed ID: 26861000
[TBL] [Abstract][Full Text] [Related]
36. Variability in Non-Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation Formulae.
Andrade JG; Hawkins NM; Fordyce CB; Deyell MW; Er L; Djurdjev O; Macle L; Virani SA; Levin A
Can J Cardiol; 2018 Aug; 34(8):1010-1018. PubMed ID: 29980468
[TBL] [Abstract][Full Text] [Related]
37. Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.
Barrios V; Górriz JL
J Comp Eff Res; 2015 Nov; 4(6):651-64. PubMed ID: 26388302
[TBL] [Abstract][Full Text] [Related]
38. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
[TBL] [Abstract][Full Text] [Related]
39. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]